PlantaCorp achieved 400% sales increase since 2018
It grew organically without external funding and is a leader in liposomal supplements.
See the latest news and media coverage for PlantaCorp. We track all announcements, press releases, and industry mentions in real time, all in one place.
Liposomal supplement contract manufacturer
plantacorp.comLast updated
In short: PlantaCorp was acquired by the Wellma Group and published clinical study results demonstrating high bioavailability for its liposomal supplements.
It grew organically without external funding and is a leader in liposomal supplements.
Their clinical trial showed 22x higher bioavailability compared to conventional tablets.
The study shows 5.18x higher bioavailability compared to standard tablets over 12 hours.
Studies show up to 5.18x higher Magnesium, 12.84x Vitamin D3, 37x Vitamin K2 D3K2, and 3.2x CoQ10 versus standards. Plantacorp urges verifiable results.
PlantaCorp, in collaboration with Surya Research Clinics, recently compared the bioavailability of four different supplemental vitamin C forms.
A CMS team led by Klaus Jäger advised Systematic Growth on all legal aspects of the transaction.
[Berlin, Apr 2024] — A groundbreaking market research report on the Liposomal Dietary Supplements Market has been ...
The Hamburg start-up PlantaCorp is expanding its production capacities and is thereby responding to the rising demand for ...
Track PlantaCorp and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.